EMBECTA Aktie

>EMBECTA Aktienkurs

12.2 EUR +0.0% (Tradegate)

Ask: 12.4 EUR / 1000 Stück

Bid: 12.3 EUR / 1000 Stück

Tagesumsatz: 5 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

EMBECTA Aktie über LYNX handeln

Intraday

1 Jahr

>EMBECTA Performance

1 Woche: +5,2%

1 Monat: -1,6%

3 Monate: +25,8%

6 Monate: +19,6%

1 Jahr: -6,2%

laufendes Jahr: -38,1%

>EMBECTA Aktie

Name:

EMBECTA CORP. DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US29082K1051 / A3DGNE

Symbol/ Ticker:

JX7 (Frankfurt) / EMBC (NASDAQ)

Kürzel:

FRA:JX7, ETR:JX7, JX7:GR, NASDAQ:EMBC

Index:

Webseite:

https://www.embecta.com/

Profil:

Embecta Corporation is a dynamic player in the hea..
>Volltext..

Marktkapitalisierung:

720.72 Mio. EUR

Unternehmenswert:

1809.35 Mio. EUR

Umsatz:

948.1 Mio. EUR

EBITDA:

274.15 Mio. EUR

Nettogewinn:

71.89 Mio. EUR

Gewinn je Aktie:

1.23 EUR

Schulden:

1305.07 Mio. EUR

Liquide Mittel:

200.89 Mio. EUR

Operativer Cashflow:

115.49 Mio. EUR

Bargeldquote:

0.85

Umsatzwachstum:

-10.4%

Gewinnwachstum:

9.06%

Dividende je Aktie:

0.51 EUR

Dividendenrendite:

4.19%

Dividendenschätzung:

4.19%

Div. Historie:

29.08.25 - 0.1287€
28.05.25 - 0.1287€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

EMBECTA

Letzte Datenerhebung:

26.10.25

>EMBECTA Kennzahlen

Aktien/ Unternehmen:

Aktien: 58.49 Mio. St.

Frei handelbar: 92.86%

Leerverk. Aktien: 4.8%

Rückkaufquote: -

Mitarbeiter: 2100

Umsatz/Mitarb.: 0.46 Mio. EUR

Analysten:

Analystenrating: Neutral

Kursziel: 20.62%

Bewertung:

KGV: 9.8

KGV lG: 4.77

KUV: 0.7

KBV: -

PEG-Ratio: 0.5

EV/EBITDA: 6.6

Rentabilität:

Bruttomarge: 61.88%

Gewinnmarge: 7.58%

Operative Marge: 24.62%

Managementeffizenz:

Gesamtkaprendite: 6.9%

Eigenkaprendite: -

>EMBECTA Peer Group

Es sind 596 Aktien bekannt.

>EMBECTA Chart & Kurs - NASDAQ

>EMBECTA News

28.08.25 - 23:37	XFRA: DIVIDEND/INTEREST INFORMATION - 29.08.2025 - US29082K1051 (XETRA)
	Das Instrument JX7 US29082K1051 EMBECTA CORP. DL-,01 EQUITY wird ex Dividende/Zinsen gehandelt am 29.08.2025 The instrument JX7 US29082K1051 EMBECTA CORP. DL-,01 EQUITY has its ex-dividend/interest day on 29.08.2025...

26.08.25 - 23:03	embecta to Participate in Investor Events (GlobeNewswire EN)
	PARSIPPANY, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:...

25.08.25 - 16:45	Embecta Corp. (EMBC) Crossed Above the 200-Day Moving Average: What That Means for Investors (Zacks)
	Good things could be on the horizon when a stock surpasses the 200-day simple moving average. How should investors react?...

12.08.25 - 17:30	Wall Street Analysts Predict a 25.69% Upside in Embecta Corp. (EMBC): Here′s What You Should Know (Zacks)
	The consensus price target hints at a 25.7% upside potential for Embecta Corp. (EMBC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term....

08.08.25 - 18:12	Embecta outlines revenue range of $1.078B-$1.085B for 2025 amid U.S. strength and China headwinds (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

08.08.25 - 12:39	Embecta Non-GAAP EPS of $1.12 beats by $0.34, revenue of $295.5M beats by $17.35M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

08.08.25 - 12:33	Embecta declares $0.15 dividend (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

08.08.25 - 12:33	Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results (GlobeNewswire EN)
	PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine month periods ended June 30, 2025....

08.08.25 - 12:03	embecta Announces Quarterly Cash Dividend (GlobeNewswire EN)
	PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company's common stock. The dividend is payable on September 15, 2025 to stockholders of record at the close of business on August 29, 2025....

24.07.25 - 23:03

embecta to Report Fiscal Third Quarter 2025 Financial Results (GlobeNewswire EN)

PARSIPPANY, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal third quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, August 8, 2025....

27.05.25 - 23:03	embecta to Participate in Investor Events (GlobeNewswire EN)
	PARSIPPANY, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:...

26.05.25 - 23:51	XFRA: DIVIDEND/INTEREST INFORMATION - 28.05.2025 - EQUBF_01 (XETRA)
	Das Instrument JX7 US29082K1051 EMBECTA CORP. DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am 27.05.2025 und ex Dividende/Zinsen am 28.05.2025 The instrument JX7 US29082K1051 EMBECTA CORP. DL-,01 EQUITY has its pre-dividend/interest day on 27.05.2025 and its ex-dividend/interest day on 28.05.2025...

24.05.25 - 03:01	Insiderhandel: Aufsichtsrat kauft Aktien von Embecta im Wert von 105995 USD (Insiderkauf)
	Melcher, David F. - Aufsichtsrat - Tag der Transaktion: 2025-05-23...

22.05.25 - 12:33	embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day (GlobeNewswire EN)
	PARSIPPANY, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta"; "The Company") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host its inaugural Analyst and Investor Day today to showcase its phased approach for value creation and present its long range financial plan (“LRP”)....

09.05.25 - 19:48	Embecta raises adjusted EBITDA margin outlook for FY 2025 amid restructuring and debt reduction (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

09.05.25 - 18:45	Why Is Embecta Stock Falling On Friday? (Benzinga)
	Embecta reaffirms earnings outlook, trims revenue forecast, and boosts cash flow as restructuring and cost controls offset tariff and FX headwinds. read more...

09.05.25 - 15:00	Embecta Corp. (EMBC) Tops Q2 Earnings Estimates (Zacks)
	Embecta Corp. (EMBC) delivered earnings and revenue surprises of 6.06% and 2.92%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...

09.05.25 - 14:39	Embecta declares $0.15 dividend (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

09.05.25 - 13:18	Embecta reports FQ2 results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

09.05.25 - 12:33	Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results (GlobeNewswire EN)
	PARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six month periods ended March 31, 2025....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Die meisten freien Schriftsteller sind nur Nebenerwerbsschriftsteller. - Dr. Fritz P. Rinnhofer

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram